# Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

> **NCT00509548** · PHASE2 · TERMINATED · sponsor: **TargeGen** · enrollment: 7 (actual)

## Conditions studied

- Macular Degeneration
- Choroidal Neovascularization

## Interventions

- **DRUG:** TG100801

## Key facts

- **NCT ID:** NCT00509548
- **Lead sponsor:** TargeGen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2010-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509548, "Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00509548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*